- Home
- FEAM vs LVTX Comparison
FEAM vs LVTX Comparison
Compare FEAM & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- LVTX
- Stock Information
- Founded
- FEAM 2016
- LVTX 2016
- Country
- FEAM United States
- LVTX Netherlands
- Employees
- FEAM N/A
- LVTX N/A
- Industry
- FEAM Major Chemicals
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FEAM Industrials
- LVTX Health Care
- Exchange
- FEAM Nasdaq
- LVTX Nasdaq
- Market Cap
- FEAM 71.5M
- LVTX 33.9M
- IPO Year
- FEAM N/A
- LVTX 2021
- Fundamental
- Price
- FEAM $3.60
- LVTX $1.30
- Analyst Decision
- FEAM Strong Buy
- LVTX Hold
- Analyst Count
- FEAM 2
- LVTX 3
- Target Price
- FEAM $121.00
- LVTX $1.75
- AVG Volume (30 Days)
- FEAM 12.7K
- LVTX 34.7K
- Earning Date
- FEAM 05-15-2025
- LVTX 08-19-2025
- Dividend Yield
- FEAM N/A
- LVTX N/A
- EPS Growth
- FEAM N/A
- LVTX N/A
- EPS
- FEAM N/A
- LVTX N/A
- Revenue
- FEAM N/A
- LVTX $4,990,000.00
- Revenue This Year
- FEAM N/A
- LVTX N/A
- Revenue Next Year
- FEAM N/A
- LVTX N/A
- P/E Ratio
- FEAM N/A
- LVTX N/A
- Revenue Growth
- FEAM N/A
- LVTX N/A
- 52 Week Low
- FEAM $2.82
- LVTX $0.85
- 52 Week High
- FEAM $31.51
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- FEAM 33.46
- LVTX 49.61
- Support Level
- FEAM $3.41
- LVTX $1.28
- Resistance Level
- FEAM $3.85
- LVTX $1.38
- Average True Range (ATR)
- FEAM 0.28
- LVTX 0.05
- MACD
- FEAM -0.06
- LVTX -0.00
- Stochastic Oscillator
- FEAM 15.24
- LVTX 26.92
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.